Charles Schwab Trust Co Acquires 99 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Charles Schwab Trust Co raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 14.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 771 shares of the healthcare conglomerate’s stock after buying an additional 99 shares during the quarter. Charles Schwab Trust Co’s holdings in UnitedHealth Group were worth $390,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Resources Management Corp CT ADV boosted its position in UnitedHealth Group by 4.2% during the 2nd quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock valued at $7,048,000 after acquiring an additional 563 shares in the last quarter. Manchester Global Management UK Ltd grew its stake in UnitedHealth Group by 12.7% in the second quarter. Manchester Global Management UK Ltd now owns 154,918 shares of the healthcare conglomerate’s stock worth $78,894,000 after purchasing an additional 17,500 shares during the period. Mill Creek Capital Advisors LLC lifted its position in UnitedHealth Group by 20.1% during the second quarter. Mill Creek Capital Advisors LLC now owns 1,983 shares of the healthcare conglomerate’s stock valued at $1,010,000 after buying an additional 332 shares during the period. Distillate Capital Partners LLC grew its position in shares of UnitedHealth Group by 563,752.2% in the 2nd quarter. Distillate Capital Partners LLC now owns 129,686 shares of the healthcare conglomerate’s stock worth $66,044,000 after buying an additional 129,663 shares during the period. Finally, Strata Wealth Advisors LLC purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $453,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $524.78 on Wednesday. The business’s fifty day moving average is $547.07 and its 200 day moving average is $563.84. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $482.95 billion, a PE ratio of 33.86, a price-to-earnings-growth ratio of 1.38 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.83 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.